Association Between High-Sensitivity C-Reactive Protein and Prognosis in Different Periods After Ischemic Stroke or

Yu Wang1,2, Jiejie Li1,2, Yuesong Pan1,2

  • 1Department of Neurology Beijing Tiantan Hospital, Capital Medical University Beijing China.

Insights

High-sensitivity C-reactive protein (hsCRP) levels within 72 hours of ischemic stroke indicate a higher risk of stroke recurrence within one year. This association was not observed when hsCRP was measured later, suggesting timing is crucial for prognosis.

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Biomarkers

Background:

  • High-sensitivity C-reactive protein (hsCRP) is an inflammatory marker.
  • The prognostic value of hsCRP timing after ischemic stroke is not fully understood.

Purpose of the Study:

  • To investigate the association between hsCRP levels and prognosis over time after acute ischemic stroke or transient ischemic attack.
  • To determine if the timing of hsCRP measurement influences its predictive value for stroke recurrence and vascular events.

Main Methods:

  • Prospective substudy of 9438 patients from the Third China National Stroke Registry.
  • hsCRP levels measured at <24 hours, 24-72 hours, and 72 hours-8 days post-onset.
  • Outcomes included 1-year stroke recurrence, combined vascular events, and poor functional outcomes (modified Rankin Scale 3-6).

Main Results:

  • Elevated hsCRP within 72 hours was associated with increased risk of 1-year stroke recurrence and combined vascular events.
  • This association was primarily observed in patients with large-artery atherosclerosis.
  • No significant association was found for hsCRP levels measured between 72 hours and 8 days post-stroke.

Conclusions:

  • Elevated hsCRP within the first 72 hours after ischemic stroke is a significant predictor of 1-year stroke recurrence.
  • The timing of hsCRP measurement is critical for its prognostic utility.
  • hsCRP measured beyond 72 hours did not show a significant association with recurrence risk.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
213
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
114
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
328
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
71
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
24